Why the study?
Does the presence of stage 2-5 chronic kidney disease increase the prevalence of left ventricular hypertrophy and alter left ventricular geometry in hypertensive patients compared to those with normal renal function?
Does the presence of stage 2-5 chronic kidney disease increase the prevalence of left ventricular hypertrophy and alter left ventricular geometry in hypertensive patients compared to those with normal renal function?
Left ventricular hypertrophy is highly prevalent and often inappropriate in hypertensive patients with chronic kidney disease, characterized by simultaneous increases in wall thickness and diameters.
Answers are grounded in this paper and cite their sources.
May warrant enhanced LV assessment in hypertensive CKD; extends cross-sectional links but leaves causal and therapeutic implications open.
OBJECTIVE: To evaluate the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2-5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function. METHODS: All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded. RESULTS: LVH was observed in 47.1% of patients with CKD and in 31.14% of essential hypertensive patients (P < 0.0001). We found increasingly higher left ventricular diameters, thicknesses, and mass from stage 2 to 5 CKD. Distribution of concentric and eccentric LVH was not different between the two groups. However, after introducing mixed hypertrophy, the difference between the two groups group was disclosed (P = 0.027). The prevalence of inappropriate left ventricular mass was 52.6% in patients with CKD vs. 30.5% in essential hypertensive patients (P < 0.0001). Multiple regression analysis confirmed that the association between renal function and left ventricular mass (beta -0.287; P < 0.0001) was independent by potential confounders. From stage 4 to 5, the significant increase of left ventricular mass was due to growth in posterior wall thickness rather than end-diastolic diameter. Diastolic function was significantly worse in patients with CKD, especially in more advanced stages. CONCLUSION: Our study confirms that LVH is highly prevalent in patients with CKD; in this population, LVH is often inappropriate and characterized by the simultaneous increase of wall thicknesses and diameters.
No takes yet. Share an insight, caveat, or question.
Nardi et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: